APOA5 antibody (N-Term)
-
- Target See all APOA5 Antibodies
- APOA5 (Apolipoprotein A-V (APOA5))
-
Binding Specificity
- N-Term
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This APOA5 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)
- Specificity
- APOA5 Antibody detects endogenous levels of total APOA5.
- Predicted Reactivity
- Pig,Bovine,Horse,Sheep
- Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogen
- A synthesized peptide derived from human APOA5, corresponding to a region within N-terminal amino acids.
- Isotype
- IgG
- Top Product
- Discover our top product APOA5 Primary Antibody
-
-
- Application Notes
- WB 1:500-1:1000, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C. Stable for 12 months from date of receipt.
- Expiry Date
- 12 months
-
- Target
- APOA5 (Apolipoprotein A-V (APOA5))
- Alternative Name
- APOA5 (APOA5 Products)
- Synonyms
- APOAV antibody, RAP3 antibody, 1300007O05Rik antibody, Apoav antibody, apo-AV antibody, apoA-V antibody, APOA5 antibody, MGC140487 antibody, rap3 antibody, apoav antibody, apoa-v antibody, apolipoprotein A5 antibody, apolipoprotein A-V antibody, apolipoprotein A5 L homeolog antibody, APOA5 antibody, Apoa5 antibody, apoa5.L antibody, apoa5 antibody
- Background
-
Description: Minor apolipoprotein mainly associated with HDL and to a lesser extent with VLDL. May also be associated with chylomicrons. Important determinant of plasma triglyceride (TG) levels by both being a potent stimulator of apo-CII lipoprotein lipase (LPL) TG hydrolysis and a inhibitor of the hepatic VLDL-TG production rate (without affecting the VLDL-apoB production rate) (By similarity). Activates poorly lecithin:cholesterol acyltransferase (LCAT) and does not enhance efflux of cholesterol from macrophages.
Gene: APOA5
- Molecular Weight
- 41 kDa
- Gene ID
- 116519
- UniProt
- Q6Q788
- Pathways
- Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
-